Tg Therapeutics TGTX
NASDAQ TGTX
$55.99 -0.72 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tg Therapeutics (TGTX) Amortizatization of Intangibles (2013 - 2026)

Tg Therapeutics (TGTX) posted quarterly Amortizatization of Intangibles of $23000.0 for Q1 2022, down 81.89% year-over-year from $127000.0 in Q1 2021, and down 76.04% quarter-over-quarter from $96000.0 in Q4 2021.

Analysis

Tg Therapeutics (TGTX) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends

Tg Therapeutics' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $23000.0 for Q1 2022.

  • In Q1 2022, Amortizatization of Intangibles fell 81.89% year-over-year to $23000.0; the TTM figure through Mar 2022 stood at $413000.0 (up 603.66% YoY), while the FY2021 annual figure was $517000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles for Q1 2022 stood at $23000.0, down from $96000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $155000.0 in Q2 2021, with the low at -$75000.0 in Q1 2019.
  • The 4-year median for Amortizatization of Intangibles is -$4500.0 (2018), against an average of $17666.7.
  • Peak annual rise in Amortizatization of Intangibles reached 42.86% in 2019, while the deepest fall reached 3850.0% in 2019.
  • Tg Therapeutics' Amortizatization of Intangibles stood at -$68000.0 in 2018, then grew by 11.76% to -$60000.0 in 2019, then surged by 260.0% to $96000.0 in 2021, then plunged by 76.04% to $23000.0 in 2022.
  • Business Quant data shows TGTX's Amortizatization of Intangibles at $23000.0 in Q1 2022, $96000.0 in Q4 2021, and $139000.0 in Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Tg Therapeutics 7.97 Bn 7.29 Bn 199.14 Mn 441,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 441,000.00
Mar 31, 2026 573,000.00
Dec 31, 2025 432,000.00
Sep 30, 2025 431,000.00
Jun 30, 2025 432,000.00
Mar 31, 2025 453,000.00
Dec 31, 2024 498,000.00
Sep 30, 2024 497,000.00
Jun 30, 2024 498,000.00
Mar 31, 2024 407,000.00
Dec 31, 2023 490,000.00
Sep 30, 2023 483,000.00
Jun 30, 2023 499,000.00
Mar 31, 2023 491,000.00
Mar 31, 2022 23,000.00
Dec 31, 2021 1.48 Mn
Sep 30, 2021 139,000.00
Jun 30, 2021 155,000.00
Mar 31, 2021 127,000.00
Sep 30, 2019 -60,000.00